Ipsol Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 6 Year, 21 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 14.25 Cr
as on 17-12-2024
- Revenue 113.34%
(FY 2021)
- Profit -85.86%
(FY 2021)
- Ebitda -80.78%
(FY 2021)
- Net Worth -185.21%
(FY 2021)
- Total Assets 114.27%
(FY 2021)
About Ipsol Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹14.25 Cr.
Surajman Vishvakarma, Jaspal Singh, Prabhash Kumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24290KA2018PTC118921
- Company No.
118921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ipsol Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surajman Vishvakarma  | Managing Director | 28-Nov-2018 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaspal Singh | Director | 23-Nov-2023 | Current |
| Prabhash Kumar | Director | 23-Nov-2023 | Current |
| Ratish Mishra | Director | 23-Nov-2023 | Current |
| Suresh Yadav | Director | 23-Nov-2023 | Current |
| Lila Mishra | Director | 10-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Ipsol Healthcare.
Ipsol Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 113.34% increase. The company also saw a substantial fall in profitability, with a 85.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 185.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ipsol Healthcare?
In 2021, Ipsol Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 08 Feb 2022 | ₹14.25 Cr | Open |
How Many Employees Work at Ipsol Healthcare?
Ipsol Healthcare has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ipsol Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipsol Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
